Cardiopulmonary Resuscitation Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 Global Cardiopulmonary Resuscitation Market is expected to register a CAGR of 10.50% during the forecast period and hit USD 300.6 Million by 2027.

Cardiopulmonary resuscitation (CPR) is an emergency and lifesaving technique. It consists of chest compression and artificial ventilation. CPR is performed to maintain the blood flow and oxygenation to the brain in case of cardiac arrest. CPR’s main function is to maintain the partial flow of oxygenated blood to the brain and heart. The main purpose is to delay tissue death to achieve successful resuscitation and protect the brain from permanent damage.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1348 

The increasing prevalence of heart and respiratory diseases, the rising geriatric population, and the rise in government initiatives are anticipated to drive the growth of the global cardiopulmonary resuscitation market. In April 2018, Stryker Launched Newest Version of LUCAS Chest Compression System in the US. The latest LUCAS 3.1 version allows professional users to tailor setup options for compression rate/depth, pause, alerts, timer, and ventilation features to meet local emergency care protocols. Moreover, in August 2019, ZOLL Medical Corporation announced acquisition of Cardiac Science. Cardiac Science Corporation is into the development, manufacturing, and marketing of automated external defibrillators (AEDs) and related parts, components, and accessories

Segment Analysis

Global Cardiopulmonary Resuscitation Market has been divided based on Product Type, Compressor Type, Application, and End User.

The market, based on Product Type, has been segregated into piston CPR devices, load-distributing band (LDB), active compression-decompression (ACD) devices and impedance threshold device, extracorporeal techniques and invasive perfusion devices, and others.

Based on compressor type, the Global Cardiopulmonary Resuscitation Market is segmented into manual CPR and automatic mechanical CPR.

The global market, on the basis of application, has been segmented into emergency departments, coronary & intensive care units, organ transplant facilities, air medevac units, and EMT rescue units.

On the basis of end-user, the market is bifurcated into the hospital & clinic, cardiac catheterization laboratories, organ transplant unit, and others.

Regional Analysis

Global Cardiopulmonary Resuscitation Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to hold the largest share of the global cardiopulmonary resuscitation market during the assessment period owing to the rise in the prevalence of lifestyle diseases and heart diseases. The Europe market is expected to register substantial growth in the market owing to the technological advancements, high disposable income, growing geriatric population, and favorable regulatory framework. Asia-Pacific is likely to hold the third-largest share of the global cardiopulmonary resuscitation market. The market in the Middle East & Africa is expected to witness gradual growth owing to the increasing number of heart & respiratory diseases coupled with rapidly developing healthcare infrastructure.

Key Players

MRFR recognizes the following companies as the Key Players in the Global Cardiopulmonary Resuscitation Market— Stryker, Nihon Kohden Corporation, ZOLL Medical Corporation, Koninklijke Philips N.V., Vyaire Medical, Inc., General Electric Company, CPR Medical Devices, Inc., Michigan Instruments, Corpuls, SCHILLER, and Medtronic.

Key Findings of the Study

• Global Cardiopulmonary Resuscitation Market was valued at USD 3 Million in 2019 and is expected to register a CAGR of 10.50% during the assessment period.
• The Americas accounted for the largest share of the global market due to the rise in the prevalence of lifestyle diseases and heart diseases.
• Based on product type, the piston CPR devices segment is expected to register the highest CAGR of 11.57% during the forecast period.
• Based on compressor type, the automatic mechanical CPR segment accounted for the largest market share at a value of USD 101.6 Million in 2019.
• Based on application, the EMT rescue units segment is expected to register the highest CAGR of 12.71% during the forecast period.
• Based on end user, the hospitals and clinic segment accounted for the largest market share at a value of USD 136.1 Million in 2027.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/cardiopulmonary-resuscitation-market-1348 

Smart Insulin Pens Market Is Seeing Explosive Growth by Future Industry Winners: Forecast, 2020-2027

 Market Research Future (MRFR) studied the global smart insulin pens market 2020 through the analysis period till 2027. By 2027, the global smart insulin pen market can expand at decent pace. On conclusion of the analysis period, the smart insulin market value can touch USD 72.97 Mn.

The escalating count of diabetics, surge in product launches and approvals, and expansion of geriatric populace can favor the smart insulin pen market in the forecast tenure. The alarming increase in diabetics across the globe due to surge in number of obese and ageing people, along with the prevailing culture of sedentary lifestyle, are creating the need for smart insulin pens. The intricate design of smart insulin pens allows refill, and Bluetooth and USB connectivity, which boost patient compliance. These causes are likely to promote the smart insulin pen market in the review period. The growing preference for homecare settings is expected to create lucrative scope for smart insulin pens manufacturers. However, high expense of insulin pens and challenges with their sales in underdeveloped nations can hinder the market growth. Investors are investing in strengthening the medical base of the market across these regions can counter the smart insulin pens market slow-down.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6789 

Segment Overview

The segment evaluation of the smart insulin pens market is based on distribution channel and product type. The product type-based segments of the smart insulin pens market are connecting device and smart pen. The smart pen segment can surge at considerable pace in the study period. The increase in sales of both smart pen and connecting device can earn high revenue for the market in the forecast tenure.  The smart pens segment can surge at 10.98% CAGR over the analysis period. The introduction of user-friendly design of smart insulin pens can prompt the market growth in the study period. As insulin pens brands focuses on innovations, the ingression of technical advances can prompt the market upsurge.

The distribution channel-based segments of the smart insulin market are hospitals or retail pharmacies, and online. The increase in number of hospital and retail pharmacies and them experiencing considerable surge in sales of smart insulin can favor the market. However, escalation of online sales of smart insulin pen as diabetic patients seek treatment and consultation on online platform can impact the market. MRFR study reveals that the hospital or retail pharmacies segment can value USD 47.97 Mn by 2027.

Regional Analysis

The smart insulin pen in the America is expected to rise at decent pace in the near future. The growth of the smart insulin pen market in the US is considerable due to rapid uptake of advanced medicines and diagnostic measures by several target patients. The presence of well-established healthcare industry and the large-scale manufacturing of medical device are causes that are expected to benefit North America market in the coming years. The emergence of new companies and active brand promotion strategies adopted by top-notch companies in the region can contribute to the expansion of the market in the coming years.

In APAC smart insulin pens market is likely to rise at the highest pace in the upcoming years. The expansion of the diagnostic health industry and increasing prominence of insulin pens can bolster the market expansion in India and other regions of APAC. The growing awareness about modern pen needles and active campaigns promoting smart insulin pens can benefit the market in the years to come. In Europe, the smart insulin market growth can be attributed to hike in investment made by international vendors to expand their global presence. The introduction of latest products for diabetes care and upscaling demand for green insulin pen can improve momentum of the market.

Competitive Landscape

Novo Nordisk A/S, Companion Medical, Digital Medics Pty Ltd., Emperra GmbH E-Health Technologies, Ypsomed Holding AG, Eli Lily and Company, and Amesco Co. Ltd., are some key players in the smart insulin market that are listed by MRFR. Adoption of strategic M&A for launching and promoting innovation can boost the competitive landscape of the smart insulin pen market in the study period. The smart insulin pens industry assessment by MRFR focuses on growth dynamics of the market that is impacted by businesses and manufacturers entering into relationships. Different firms are developing innovations in pump therapy and advanced glucose monitoring to boost patient medication compliance for growing cases of type 2 diabetes. The rise of the smart insulin pens and pumps market can also be attributed to product development by top-notch companies.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/smart-insulin-pens-market-6789 

Global EPharmacy Market Show Steady Growth: Study 2027

 The restrictions created by the COVID pandemic created a promising situation for the development of the ePharmacy market. Reports created by MRFR detail the developments in the industry that can be expected in the market through the forecast period. The market is predicted to achieve development with a CAGR of 12.5% by 2027.

The enhancement of distribution chains associated with pharmaceutical drugs is predicted to create impetus in the forecast period's ePharmacy market. The cost advantages are estimated to further promote the advancement of the ePharmacy market in the coming period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6615 

Segment Analysis

Global ePharmacy Market has been divided based on drug Type, Operating Platform, and Business Model.

The market, based on drug type, has been segregated into prescription drugs and over the counter (OTC) drugs.

Based on operating platform, the ePharmacy market has been divided into app and websites.

On the basis of business model, the ePharmacy market is segregated into the marketplace, pharmacy, and direct.

Regional Analysis

The global ePharmacy market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is likely to hold the largest share of the global ePharmacy market during the assessment period owing to the presence of a large number of ePharmacy in the region. Some of the renowned ePharmacy in the region include Walgreens Boots Alliance, Inc., Wal-Mart, Inc., CVS Health, PillPack, Inc., and others. According to a 2019 survey, 19% of health care providers in the U.S. offer a customer’s web-based prescription refill online program. It was also reported that several retail pharmacies have been offering mobile apps for an online prescription refill. A large number of companies such as Walgreens and CVS Pharmacy offer mobile apps to make prescription refill easy and convenient with a round to clock delivery. The ePharmacy market in Europe is expected to propel during the forecast period, owing to factors such as rising government initiatives, increasing awareness among customers regarding ePharmacy, and the convenience associated with the offered services. The fast growth of the Asia-Pacific region is due to rising investment for ePharmacy startups and the increasing per capita income along with government initiatives to enhance the quality of healthcare. China, India, and Australia have a lucrative market for ePharmacy due to the growing investment. The online pharmacy market in India attracted funding of USD 93 million by 2015. As a result, 60 online pharmacy start-ups emerged in 2017.

Key Players

MRFR recognizes the following companies as the Key Players in the Global ePharmacy Market— Walgreens Boots Alliance, Inc., Wal-Mart, Inc., CVS Health, Dr. Fox Pharmacy, DocMorris N.V., Rowlands Pharmacy, OptumRx, The Online Drugstore, Well Pharmacy, LloydsPharmacy and Others.

Key Findings of the Study

• The Global ePharmacy Market was valued at USD 62,587.0 Million and is expected to register a CAGR of 12.5% during the assessment period

• The Americas accounted for the largest share of the global market due to the increasing preference of customers to buy medications online and growth in the number of ePharmacy. These factors are driving the growth of the ePharmacy market in the region

• Based on the drug type, the prescription drugs segment accounted for the largest market share of 55.6% in 2019

• Based on the operating platform, the app segment accounted for the largest market share of 57.6% in 2019

• Based on the business model, the marketplace segment accounted for the largest market share with a value of USD 28,813.3 Million in 2019

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/epharmacy-market-6615 

Patient Handling Equipment Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 Market Research Future (MRFR) expects the patient handling equipment market to attain a valuation of USD 15,430.18 Million by 2027. MRFR also anticipates the market to thrive at a rate of 8.3% over the forecast period (2020-2027).

Key Players Locking Horns:

The patient handling equipment industry is rife with a number of players indulging in intense competition. Many of these companies are focused on carrying out extensive research and development activities to introduce new products that have multiple applications. Leading companies also adopt a number of organic as well as inorganic growth tactics, such as mergers & acquisitions, innovative product launches and expansions to enhance their share in the global industry.

Malvestio Spa (Italy), Stryker (US), Invacare Corporation (US), Handicare (Sweden), GF Health Products, Inc. (US), Arjo (Sweden), Joerns Healthcare LLC (US), Prism Medical UK (UK), McAuley Medical, Inc. (US), Etac AB (Sweden), EZ Way, Inc. (US), LINET (Czech Republic), Savaria (Canada), Medline Industries, Inc. (US), Ossenberg GmbH (Germany), Stiegelmeyer GmbH & Co. KG (Germany), Hill-Rom Services Inc. (US) are some of the most renowned vendors in the global market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9986 

Future Growth Boosters:

Governments are increasingly laying down guidelines and regulations pertaining to manual handling in healthcare, which are expected to be followed diligently and can help boost the demand for patient handling equipment in the near future. For instance, the National Institute of Occupational Safety & Health’s regulations with respect to the lifting equation with Recommended Weight Limit (RWL) help ensure that the patients are effectively handled, and the caregivers are not subjected to any risk of injury.

Furthermore, rising burden of disabilities worldwide combined with the growth of the elderly population prone to a number of disorders should foster the sales of patient handling equipment in the following years. The World Health Organization reported in 2014 that out of the total number of diseases in 2021, close to 1.18 million patients will be afflicted with some form of disability while the number by 2031 will reach 1.43 million patients. It is also expected that the frequent introduction of technical enhanced and safe device or equipment that are easy to operate by the caregivers, while also helping avoiding MSDs should work in the favor of the global market.

Segmentation:

Product, application and end-user are the top market segments listed in the MRFR report.

Product-based key segments are bathroom & toilet assist equipment, stretchers & transport chairs, ambulatory aids, patient transfer devices, wheelchairs & mobility scooters, medical beds, and others.  Patient transfer devices stand as the leading segment in the market on account of the growing prevalence of obesity worldwide. Meanwhile, medical beds are generating robust demand as well, with electric beds, semi-electric beds and manual beds gaining high traction.

Applications of patient handling equipment include mobility assistance, long term care, acute & critical care, and more. Acute & critical care segment is most likely to attain the top spot, in view of the significant increase in the rate of viral infections, cardiovascular diseases, and various acute diseases. Long term care segment can procure the fastest growth rate, owing to the significant burden of target diseases like tetanus, Alzheimer’s disease, tuberculosis, and others.

Major industry end-users are hospitals, home care settings and others. Hospitals segment is in the lead, in line with the developments in healthcare infrastructure along with the surge in healthcare spending.

Regional Status:

Europe, Americas, MEA or Middle East & Africa and Asia Pacific or APAC are the major regions that have been focused on in the MRFR report to analyze the growth prospects of the global market.

The lead has been taken by the American market, in view of the escalating obesity cases, in addition to various other chronic diseases. Heightened preference for home care equipment, expanding geriatric population, and favorable government aid in developing medical infrastructure can further benefit the patient handling equipment market in the region. Another growth rendering aspect has been the surge in musculoskeletal disorder rate in the region, which also bolsters the product demand.

Europe stands as the second most lucrative market for patient handling equipment, thanks to the significant number of research and development activities taking place in the region, backed by large-scale investments. Europe further benefits from the presence of a huge number of well-equipped medical facilities, skilled professionals, and the soaring demand for improved healthcare services. Supportive standards pertaining to patient safety and the surging prevalence of lifestyle and chronic diseases also add to the value of the patient handling equipment market in the region.

The APAC market should continue to soar rapidly and attain the fastest growth rate during the evaluation period. Some of the key growth boosters include the mounting cases of MSD-caused injuries, expanding older population and the improvement in the healthcare infrastructure. Substantial prominence of chronic ailments in the region also fosters growth. A number of countries have imposed policies regarding safe handling to avoid injury to caregivers while lifting patients. This has encouraged the adoption of patient handling equipment in the healthcare industry. Moreover, the fast economic growth of China, India, as well as Southeast Asia has prompted global players to invest significantly in this region, presenting attractive opportunities.

Latest Developments:

February 2021

Stryker, a reputed medical technology firm, has launched a wireless hospital bed series, ProCuity. The bed helps bring down the number of patient falls at every acuity level and bolster the nurse workflow safety as well as efficiency. The bed connects smoothly with the nurse call systems with no requirement for wires or cables. The medical bed is ergonomically developed with advanced technologies to promote intuitive positioning of the patient along with bed alarms and side rails.

Developments Post COVID-19 Outbreak

The entire healthcare sector has been deeply affected by the COVID-19 pandemic, resulting in weakened demand for patient handling equipment. The lockdown has lowered the workforce across the manufacturing units, leading to reduced production capacity. The novel coronavirus has also thrown challenges at the players in the form of revenue losses, debts, weaker supply chains, to name a few.

The accelerated cases of SARS-CoV-2 have compelled manufacturers to follow strict safety norms and maintain efficient communication, as employees’ health has become the key focus. It is also expected that the patient handling equipment industry can pick up pace in the coming years, backed by the surge in digitization in the healthcare industry.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/patient-handling-equipment-market-9986 

Research report covers the Medical Payment Fraud Detection Market Forecasts and Growth, 2020-2027

 Health fraud is an intentional deception or misrepresentation of fact that can result in unauthorized benefit or payment.

The growth of the medical payment fraud detection market is due to the unpredicted surge of healthcare scams and fraud during the COVID 19 outbreak, a rising number of patients opting for health insurance, and rising healthcare expenditure.

Furthermore, a large number of false or fake activities, increasing pressure of fraud and abuse on healthcare spending, and growing pressure to increase operational efficiency and reduce healthcare spending, are also expected to fuel the market during the forecast period.

However, the lack of skilled professionals and unwillingness to adopt the fraud analytics system in developing countries are expected to restrain the growth of the medical payment fraud detection market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9778 

Several market players such as SAS Institute, LexisNexis Risk Solutions, and Optuminsight, among others currently dominate the global medical payment fraud detection market.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2020, owing to the increasing number of patients opting for health insurances. For Instance, according to the Centers for Disease Detection and Prevention, in 2018 report, 25.5% people under age of 65 opted for public health insurance in the United States. The medical payment fraud detection market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European medical payment fraud detection market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, Italy, Spain, the UK and the rest of Western Europe. The medical payment fraud detection market in Asia-Pacific has been segmented into Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific. Due to large number of fraudulent activities, the market in Asia-Pacific is expected to be the fastest-growing. The medical payment fraud detection market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

Global Medical Payment Fraud Detection Market has been segmented based on the Type, Component, Delivery Model, Source of Services, and End User.

Based on Type, the global medical payment fraud detection market has been segmented into descriptive analytics, predictive analytics, and prescriptive analytics. Descriptive analytics forms the base for the effective application of predictive and prescriptive analytics.

On the basis of components, the market has been segmented into services and software. Software fraud detection is expected to hold a major market share.

Based on the delivery model, the market has been segmented into on-premise and cloud-based. The cloud-based fraud detection market is expected to gain traction during the forecast period.

On the basis of the source of service, the market has been segmented into in-house and outsourced.

The market based on end-user has been segmented into private insurance payers, public/ government agencies, and third-party service providers.

Key Players

Some of the key players in the global medical payment fraud detection market are LexisNexis Risk Solutions (US), International Business Machines Corporation (US), Optuminsight (US), OSP Labs (India), DXC Technology Company (US), UnitedHealth Group (US), SAS Institute (US), Fair Issac Corporation (US), EXL Service Holdings, Inc. (US), CGI GROUP (Canada).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-payment-fraud-detection-market-9778 

Research report covers the Microtome Market Forecasts and Growth, 2020-2027

 According to MRFR analysis, Microtome Market is expected to register a CAGR of 6.1% during the forecast period of 2019 to 2025 and accounts for USD 120 million in 2018.

A microtome is a tool used to cut extremely thin sections of tissue samples. Microtomes help in extremely fine cuts that are important for preparations used in microscopy. Different kinds of microtomes made up of metals and glass are used depending on the type of specimen and the desired thickness.

The growth of the global microtome market is driven by various factors such as an increase in the incidence of chronic disorders, increasing prevalence of lifestyle diseases, and increasing mergers & acquisitions by prominent players in the market. However, lack of skilled workforce is projected to hamper the growth of the global microtome market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8568 

The global microtome market is currently dominated by several market players such as Danaher Corporation, Thermo Fisher Scientific, and Sakura Finetek, among others. Additionally, growing growth strategies adopted by market players are driving the growth of the market. For instance, in 2018, Sakura Finetek launched Accu-Cut SRM 300 LT, manual microtome.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising per capita healthcare expenditure. The microtome market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European microtome market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The microtome market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing prevalence of chronic disorders and increasing patient pool, the market in Asia-Pacific is expected to be the fastest-growing. The microtome market in the Middle East & Africa has been bifurcated into the Middle East and Africa.

Segmentation

The Global Microtome Market has been segmented based on product, application, technology, and end-user.

The market, based on product, has been divided into instruments and accessories. Instruments are further sub-segmented into rotary microtomes, cryostat microtomes, vibrating microtomes, and others. Instruments are expected to hold the largest share, due to the commercial availability of these systems and their high adoption rate due to ease of handling.

In terms of application, the global microtome market has been segmented into disease diagnosis and medical research. Disease diagnosis takes up the largest share due to the increasing number of tissue examinations in research laboratories and hospitals owing to rising awareness about the benefits of early diagnosis of diseases like cancer.

In terms of technology, the global microtome market has been segmented into manual, semi-automated microtomes, and fully automated microtomes. The fully automated segment held the majority share due to rising demand for technologically advanced products and its ability to show the highest precision in section thickness. Additionally, fully automated microtomes do not require tedious manual adjustments.

In terms of end-user, the global microtome market has been segmented into hospital laboratories and clinical laboratories. Hospital laboratories take up the largest share. The positive growth of hospitals is attributed to factors such as a high volume of routine tissue examinations performed in hospital-based laboratories across the globe and growing patient population.

Key Players

Some of the key players in the Global Microtome Market are Amos Scientific Pty Ltd (Australia), Danaher (US), Diapath S.p.A. (Italy), Histo-Line Laboratories (Italy), Jinhua YIDI Medical Appliance Co., Ltd (China), MEDITE GmbH (Germany), Boeckeler Instruments, Inc. (US), Sakura Finetek (Japan), SLEE Medical GmbH (Germany), and Thermo Fisher Scientific (US)

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/microtome-market-8568 

Global Menopause Treatment Market Show Steady Growth: Study 2027

Global Menopause Treatment Market is expected to have a market value of USD 15,456.3 Million by 2027. Menopause causes uncomfortable symptoms, such as hot flashes, vaginal dryness, and weight gain and menopause treatments such as hormonal and non-hormonal treatments help to relieve these symptoms. Over the years, major market players in the menopause treatment are focusing on various growth strategies such as product launches, product advancements and expansions to cater to the growing needs for patients seeking treatment for menopause symptoms. For instance, in April 2019, Otsuka Pharmaceutical launched EQUELLE, a non-prescription, non-hormonal supplement to alleviate the frequency of hot flashes and muscle aches associated with menopause in the US. Such strategies push the demand for branded as well as generic menopausal drugs, thus promising huge growth for the industry.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4579 

Segment Analysis

The global menopause treatment market is segmented based on treatment and distribution channel.

The global menopause treatment market based on the treatment has been segmented into hormonal treatment and non-hormonal treatment. The hormonal treatment segment is further segmented into estrogen, progesterone, and combination. The non-hormonal treatment is further segmented into anti-depressants and others.

Based on distribution channel, the menopause treatment market is segmented into hospital pharmacies, retail pharmacies, and online stores.

Regional Analysis

The global menopause treatment market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.

The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas led the market and accounted for the largest share in 2019 owing to the increasing product approvals and high uptake of new technology.  For instance, in July 2017, AMAG Pharmaceuticals, Inc. (US) launched Intrarosa (prasterone) for the treatment of moderate to severe dyspareunia a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Thus, such strategies employed by major players aid in the increased growth rate for the Americas menopause treatment industry.

The European menopause treatment market has been further segmented into Western Europe and Eastern Europe. The Western Europe menopause treatment market has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. Europe follows the Americas in the global menopause treatment market. The increasing inclination of companies towards female technology (femtech) is boosting the growth of the menopause treatment market in European countries. Many digital health start-ups have identified this opportunity and are offering B2C digital health tools, such as mobile apps, to guide menopausal women through this phase with lifestyle intervention tips and online telehealth consultations. As a result, the region is expected to show significant growth in the menopause treatment market.

The menopause treatment market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is expected to register the highest growth rate over the forecast period from 2020 to 2027. This is owing to the growing penetration of the women’s health sector, increasing awareness about the betterment of the women’s health, and the growing number of educational campaigns related to the benefits of hormone replacement therapy in China, Japan, India, and Australia.

The Middle East & Africa menopause treatment market is segmented Saudi Arabia, the United Arab Emirates (UAE), Oman, Kuwait, Qatar, and the rest of the Middle East & Africa. The negative connotation of menopause has resulted in a negative attitude towards menopause in premenopausal women. However, with the increasing awareness created by private companies, the scenario is expected to change in the next ten years.

Key Players

MRFR recognizes the following companies as the Key Players in the Global Menopause Treatment Market— Novo Nordisk A/S (Denmark), Pfizer Inc. (US), Allergan (Ireland), Eli Lily and Company (US), Emcure Pharmaceuticals Ltd (India), Novartis AG (Switzerland), Cipla Inc. (India), Teva Pharmaceuticals (Israel), Merck & Co., Inc. (US), Abbott Laboratories (US).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/menopause-treatment-market-4579